Trial of Bendamustine And Rituximab for Patients With Previously Untreated Extranodal Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma

NCT01015248 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

MALT LYMPHOMA

Interventions

DRUG: Rituximab and Bendamustine

Sponsor

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea